Does Chemotherapy Cause Hallucinations: How It Works, Results and What to Expect

Chemotherapy can be associated with hallucinations, but this is uncommon and is often linked to delirium, medication effects, infection, dehydration, organ changes, or other complications during cancer treatment rather than chemotherapy alone. New hallucinations, severe confusion, or sudden behavior changes should be assessed promptly by the cancer care team.

Does chemotherapy cause hallucinations?

Yes, chemotherapy can be associated with hallucinations in some situations, but hallucinations are not a common or expected chemotherapy side effect. They may occur when cancer treatment contributes to delirium, a sudden change in attention and awareness. However, hallucinations during treatment are often related to several factors together, such as other medicines, infection, dehydration, sleep loss, pain, low oxygen levels, or changes in kidney, liver, electrolyte, or blood sugar function.

A hallucination is sensing something that is not present, such as seeing people or objects, hearing voices or sounds, or feeling sensations on the skin. It can be frightening for the person and family, but it is a medical symptom rather than a personal failing. The care team should be informed promptly, especially if symptoms are new, sudden, worsening, or accompanied by confusion.

This article explains how these symptoms may arise during cancer treatment, what clinicians look for, and what recovery may involve. It does not replace individualized medical advice, since the urgency and likely causes depend on a person’s cancer, treatment plan, medical history, and current symptoms.

How chemotherapy and cancer treatment can affect thinking

Chemotherapy uses medicines that damage or slow the growth of cancer cells. Some medicines may also affect healthy tissues and body systems, causing effects such as fatigue, nausea, reduced appetite, nerve symptoms, or changes in blood counts. Cognitive symptoms can occur during or after treatment, although the exact mechanisms are complex and differ between individuals and treatment regimens.

The term “chemo brain” is commonly used for difficulties with concentration, processing speed, multitasking, word-finding, memory, and mental organization. These symptoms are usually subtler than delirium. A person with chemo brain may need more time to follow a conversation or remember an appointment, while a person with delirium may be unable to sustain attention, may become disoriented, and can have major fluctuations over hours.

Hallucinations are more likely to signal delirium or another acute medical issue than ordinary chemo brain. Cancer itself may also affect cognition through pain, emotional stress, poor sleep, nutritional difficulties, spread of disease to the brain, or complications involving organs and metabolism. A careful assessment is therefore important rather than assuming that chemotherapy is the only cause.

Who may be more likely to develop hallucinations or delirium?

Anyone receiving cancer treatment can develop sudden confusion, but risk may be higher in older adults and in people who are already medically unwell or frail. Previous memory problems, dementia, depression, anxiety, poor sleep, alcohol or substance withdrawal, and previous episodes of delirium can also increase vulnerability.

During treatment, clinicians consider whether a person has an infection, fever, dehydration, constipation, uncontrolled pain, anemia, low oxygen, or abnormal levels of sodium, calcium, glucose, or other substances in the blood. Reduced kidney or liver function can change how medicines are cleared from the body and may increase side effects.

Several supportive medicines can sometimes contribute to confusion or hallucinations, particularly when combined or used in a person who is sensitive to their effects. These may include opioid pain medicines, corticosteroids, sedatives, sleep medicines, anticholinergic medicines, and some anti-nausea treatments. This does not mean these medicines should be avoided when they are needed; rather, their benefits, timing, dose, and alternatives should be reviewed by the treating team.

• Recent medicine additions, dose changes, or missed doses are important to report.
• Family members can help by noting when symptoms started and whether they fluctuate.
• New hallucinations after chemotherapy should never be managed by stopping prescribed treatment independently.

How clinicians assess new hallucinations during chemotherapy

Assessment begins with a focused history from the person and, when possible, a family member or caregiver. The team asks when symptoms began, whether they come and go, what the person is seeing or hearing, how alert they are, and whether there are related symptoms such as fever, headache, weakness, shortness of breath, pain, vomiting, poor fluid intake, falls, or sleep disruption.

A clinician may check vital signs, hydration, oxygen level, neurological function, and orientation. Blood and urine tests may help identify infection, metabolic changes, anemia, kidney or liver problems, or medication-related complications. Depending on the symptoms and cancer history, imaging of the brain or other investigations may be needed to assess for stroke, bleeding, seizures, or cancer-related changes.

The goal is to identify reversible causes quickly while maintaining comfort and safety. Oncology care may involve input from emergency medicine, internal medicine, neurology, psychiatry, palliative care, pharmacy, nutrition, and rehabilitation specialists. Chemotherapy treatment planning can include review of side effects and supportive care needs throughout each treatment cycle.

Treatment, benefits, risks and recovery expectations

There is no single treatment for hallucinations during cancer care because management depends on the cause. Clinicians may treat an infection, correct dehydration or electrolyte changes, improve pain control, address constipation or urinary retention, provide oxygen when appropriate, or adjust medicines that may be contributing. If cancer treatment itself is strongly suspected, the oncologist may consider changes to timing, supportive medicines, or the regimen while balancing cancer-control goals and overall wellbeing.

During an episode of delirium, a calm and familiar environment can be helpful. Gentle reorientation, daylight exposure, use of glasses or hearing aids, regular sleep routines, hydration when medically appropriate, and the presence of a trusted caregiver may reduce distress. Medication for severe agitation or distress may occasionally be considered by clinicians, but is not routinely needed for every person.

The benefit of prompt assessment is that many triggers can be treated or improved. The main risks of delaying care include falls, missed medications, dehydration, inability to report symptoms, and overlooking an infection or other urgent condition. Recovery varies: some people improve within hours or days after the cause is addressed, while others recover more gradually, particularly after a prolonged illness or multiple contributing factors.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support international patients who need evaluation and treatment during cancer care, including coordination of oncology and relevant supportive services.

When to seek medical care

Contact the oncology team urgently if a person receiving chemotherapy develops a new hallucination, marked confusion, unusual drowsiness, disorientation, personality change, or inability to focus. Even if symptoms appear mild or pass quickly, they should be reported because delirium can fluctuate and an underlying cause may require treatment.

Emergency medical assessment is particularly important if confusion or hallucinations occur with fever, a severe headache, fainting, seizure-like activity, new weakness or numbness, difficulty speaking, chest pain, trouble breathing, a fall or head injury, persistent vomiting, or inability to drink fluids. People with low white blood cell counts may need urgent assessment for fever or signs of infection.

Until help is available, a family member should stay with the person if possible, reduce noise and stimulation, avoid arguing about what they are experiencing, and bring a current list of medicines and recent treatment details. Do not drive, drink alcohol, take unprescribed sedatives, or make medication changes without advice from a clinician.

When do cancer patients start hallucinating?

Cancer patients can start hallucinating at different points: before treatment, during a chemotherapy infusion or treatment cycle, after a new medicine is started, during hospitalization, or later in the course of illness. The timing alone does not identify the cause. Symptoms may begin abruptly over hours, particularly with delirium, or develop after a period of poor sleep, poor intake, infection, or medication accumulation.

Some people may be more aware of symptoms at night, when fatigue, unfamiliar surroundings, and disrupted sleep can worsen confusion. Hallucinations can also fluctuate, meaning a person may seem clearer at one time of day and more confused later. This pattern is one reason caregivers’ observations are valuable.

Because new hallucinations can have treatable causes, the cancer team should be contacted as soon as they occur. The team can determine whether same-day review, urgent testing, or emergency care is most appropriate.

How long does chemo brain usually last?

Chemo brain often improves after treatment ends, but its duration varies. Some people notice improvement within weeks or months as fatigue, sleep, appetite, and activity levels recover. Others have cognitive changes that last longer, especially when cancer treatment has included multiple therapies or when other health conditions affect memory and concentration.

Chemo brain usually involves mild to moderate cognitive changes rather than acute hallucinations or severe disorientation. Keeping a written schedule, using reminders, doing one task at a time, taking rest breaks, maintaining regular sleep, and discussing rehabilitation or cognitive support with the care team may be useful.

Persistent, worsening, or functionally significant symptoms should be evaluated. Clinicians may look for treatable contributors such as depression, anxiety, anemia, thyroid problems, nutritional deficiencies, medication side effects, pain, and sleep disorders.

What is the most common cognitive side effect of chemotherapy?

The most commonly reported cognitive concerns after chemotherapy are problems with attention, concentration, short-term memory, processing speed, and executive function. Executive function includes planning, organizing, switching between tasks, and keeping track of several steps. People may describe feeling mentally foggy or slower than usual.

These symptoms can be affected by chemotherapy but may also reflect fatigue, emotional stress, sleep disruption, pain, hormonal treatment, surgery, radiation, or the cancer itself. A symptom diary can help clarify patterns around treatment days, medication changes, and sleep or nutrition difficulties.

Hallucinations are not considered a typical chemo brain symptom. Their presence warrants a more urgent clinical assessment for delirium, medication effects, infection, metabolic changes, or neurological causes.

How long does delirium last in cancer patients?

Delirium in cancer patients may last hours, days, or longer, depending on its cause and how quickly it can be treated. When a reversible trigger such as dehydration, infection, medication effect, or metabolic imbalance is identified and corrected, improvement may occur relatively quickly. Delirium can also fluctuate during recovery, so short periods of clarity do not always mean the issue has fully resolved.

In some people with advanced illness or several medical complications, delirium may be more persistent. The care team will focus on comfort, safety, communication, and treating causes that can reasonably be addressed. Families should ask what changes to expect and how they can support orientation and comfort.

Any suspected delirium deserves prompt professional review. Early support may reduce distress and help clinicians identify important complications while they are still manageable.

Frequently asked questions

Can chemotherapy directly cause hallucinations?

Some chemotherapy medicines may contribute to neurological or cognitive side effects, but hallucinations are uncommon. More often, they occur in the context of delirium caused by a combination of medicines, infection, dehydration, metabolic changes, sleep disruption, or other medical complications. New hallucinations should be reported promptly to the cancer care team.

Are hallucinations during chemotherapy always a sign of cancer spreading to the brain?

No. Hallucinations do not automatically mean that cancer has spread to the brain. There are many possible causes, including medication effects, infection, metabolic problems, and delirium. A clinician may recommend brain imaging or other tests when symptoms and medical history make this necessary.

What should a caregiver do if a person receiving chemotherapy is hallucinating?

Stay calm, remain with the person when possible, and contact the oncology team or urgent medical services based on symptom severity. Avoid confrontation about what the person is seeing or hearing, as this can increase distress. Bring a medication list and note the timing of symptoms, recent treatments, fever, fluid intake, and other changes.

Can steroids used with chemotherapy cause hallucinations?

Corticosteroids can sometimes cause mood, sleep, thinking, or perception changes, including hallucinations in susceptible individuals. Risk can depend on the person, the medicine, the treatment duration, and other medicines being used. The prescribing clinician should assess these symptoms before any treatment changes are made.

Is chemo brain the same as delirium?

No. Chemo brain generally describes milder, often gradual difficulties with memory, focus, organization, and mental speed. Delirium is a sudden change in awareness and attention that can include disorientation, agitation, drowsiness, and hallucinations. Delirium needs prompt medical evaluation.

Will hallucinations go away after chemotherapy stops?

They may improve when the underlying cause is identified and treated, but stopping chemotherapy alone may not resolve them if another issue is responsible. The oncology team can determine whether chemotherapy, supportive medicines, infection, metabolic changes, or another condition is contributing. It is important not to stop treatment without professional guidance.

References

• National Cancer Institute
• American Cancer Society
• National Institute on Aging
• American Society of Clinical Oncology
• National Comprehensive Cancer Network

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.